Evidence map›Paper›PMID 39488578›Full record

ArticleScientific reports2024

Enhanced antimicrobial efficacy of hydroxyapatite-based composites for healthcare applications.

Maher Hassanain, Hamdy Maamoun Abdel-Ghafar, Hamed I Hamouda, Fouad I El-Hosiny, Emad M M Ewais

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maher HassanainCentral Metallurgical Research and Development Institute (CMRDI), PO Box 87, Helwan, Cairo, 11421, Egypt.
Hamdy Maamoun Abdel-GhafarCentral Metallurgical Research and Development Institute (CMRDI), PO Box 87, Helwan, Cairo, 11421, Egypt. hamdy.maamoun@gmail.com.
Hamed I HamoudaDalian Engineering Research Center for Carbohydrate Agricultural Preparations, Liaoning Provincial Key Laboratory of Carbohydrates, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, CAS, Dalian, 116023, China.
Fouad I El-HosinyChemistry Department, Faculty of Science, Ain Shams University, Abbassia, Cairo, 11566, Egypt.
Emad M M EwaisCentral Metallurgical Research and Development Institute (CMRDI), PO Box 87, Helwan, Cairo, 11421, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydroxyapatite (HAp) and hydroxyapatite-based materials show promising potential in the healthcare sector due to their distinctive properties such as biocompatibility, antimicrobial efficacy, non-toxicity, and robust mechanical characteristics. This makes HAp materials play an important role in hindering infection spreading in healthcare provider institutions. This study assesses the antimicrobial efficacy of the developed hydroxyapatite-based composites incorporating copper, zinc, and silver nanoparticles. The synthesized HAp and its modified composite variants (Cu/HAp, Zn/HAp, and Ag/HAp) with varying ratios ranging from 0 to 15% (wt) were characterized using XRD, XPS, SEM, and TEM analyses. Furthermore, the antibacterial and antifungal properties of the synthesized HAp and HAp-based composites were evaluated. The antibacterial effectiveness of the HAp and its composites was evaluated using a modified disc diffusion test, where the resulting inhibition zones on the agar surface were observed. All the HAp and HAp-based composites (HAp, Cu/HAp, Zn/HAp, and Ag/HAp materials) elicited in the formation of inhibitory zones. The most substantial inhibition values were observed for the 5% Ag/HAp formulation, with values of 19.7 and 13.8, against E. coli and S. aureus, respectively. The 5% Ag/HAp concentration may strike an ideal balance, providing high antimicrobial activity without adverse effects on biocompatibility or material stability. These findings underscore the recommendation of the proposed HAp-based composites for infection control measures through their application on medical instruments, textiles, healthcare personnel attire, and patient garments.

Indexed as

DurapatiteEscherichia coliMetal NanoparticlesSilverStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective AgentsBiocompatible MaterialsCopperHumansMicrobial Sensitivity TestsX-Ray DiffractionZincAnti-Bacterial AgentsAnti-Infective AgentsBiocompatible MaterialsCopperDurapatiteSilverZincAnti-microbialCopperHydroxyapatiteSilverWet chemical precipitationZinc

Identifiers

PMID39488578
PMCPMC11531545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.